SCHEMBL4428037

SCHEMBL4428037

CC(=O)C(c1ccc(C(F)(F)F)cc1)c1ccc2c(c1)CCCC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 6/20 0.46
KMT2A Q03164 2/20 0.45
HTT P42858 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 2/20 0.42
HSP90AA1 P07900 1/20 0.42
GAA P10253 1/20 0.42
ACACB O00763 1/20 0.41
KCNH2 Q12809 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2D6 P10635 1/20 0.39
HSD17B1 P14061 1/20 0.39
HSD17B2 P37059 1/20 0.39
HSD17B4 P51659 1/20 0.39
CYP3A4 P08684 1/20 0.38
NOTUM Q6P988 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
CES2 O00748 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4438441 0.83 TRPV1 (0.43) TRPV1KMT2AHTTMEN1ALDH1A1
SCHEMBL4433151 0.82 HDAC3 (0.47) TRPV1KMT2AACACBKCNH2
SCHEMBL4435291 0.81 TRPV1 (0.45) TRPV1KMT2AHTTMEN1ALDH1A1
SCHEMBL4438527 0.77 CES2 (0.50) KMT2AMEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL4431561 0.77 AKR1C3 (0.48) ALDH1A1CES2CES1
SCHEMBL4432335 0.77 CES2 (0.41) CES2CES1
SCHEMBL2304585 0.76 ACP3 (0.56) ALDH1A1CES2CES1
SCHEMBL4432365 0.74 AKR1C3 (0.43) ALDH1A1CES2CES1
SCHEMBL4435426 0.73 CNR1 (0.40) CES2CES1LMNA
SCHEMBL4434628 0.73 AKR1C3 (0.51) KMT2AMEN1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114867-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. Hoffmann-Roche AG (CH) 2009-11-11 EP disclosed
WO-2008107335-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-09-12 WO disclosed